Document Detail


A Chinese Diabetes Risk Score for Screening of Undiagnosed Diabetes and Abnormal Glucose Tolerance.
MedLine Citation:
PMID:  21406016     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background: This study is aimed at developing and evaluating a diabetes risk score (DRS) to predict incident diabetes and screen for undiagnosed diabetes and abnormal glucose tolerance in the Chinese population. Methods: Three DRS instruments were respectively developed and validated based on the data collected from a 10-year longitudinal health checkup-based population of 1,851 individuals without diabetes at baseline. The efficiency on glucose abnormality screening was evaluated based on the testing of a cross-sectional sample of 699 individuals without known diabetes. Results: The DRS consisting of age, hypertension, history of high blood glucose, body mass index, fasting plasma glucose, serum triglycerides, and serum high-density lipoprotein-cholesterol had the best prediction properties (area under curve [AUC] = 0.734 [95% confidence interval 0.702-0.766] and 0.759 [0.686-0.831] in exploratory and validation cohorts, respectively). The DRS had a sensitivity of 64.5% and 72.9%, respectively, and a specificity of 71.6% and 63.9%, respectively, with an optimal cutoff of 4. AUCs were 0.828 (0.797-0.860) and 0.909 (0.884-0.933) for detecting abnormal glucose tolerance and diabetes, respectively, through cross-sectional screening. Performance of the oral glucose tolerance test (OGTT) in selected subjects with DRS ≥4 led to the identification of 76.2% cases of abnormal glucose tolerance and 100% cases of diabetes, while avoiding an OGTT in 52.8% of the study group. Conclusions: The DRS instrument including age, hypertension, history of high blood glucose, body mass index, fasting plasma glucose, triglycerides, and high-density lipoprotein-cholesterol is practical and effective in predicting incident diabetes and screening glucose abnormality in the Chinese population.
Authors:
Min Liu; Changyu Pan; Mengmeng Jin
Related Documents :
20935516 - The emerging role of autophagy in the pathophysiology of diabetes mellitus.
17095586 - Receptor for advanced glycation end products activation injures primary sensory neurons...
20632216 - Glycolaldehyde induces oxidative stress in the heart: a clue to diabetic cardiomyopathy?
20213326 - Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in...
12007726 - Glycemic response during exercise after administration of insulin lispro compared with ...
16186276 - Glycemic status and development of kidney disease: the framingham heart study.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-15
Journal Detail:
Title:  Diabetes technology & therapeutics     Volume:  -     ISSN:  1557-8593     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100889084     Medline TA:  Diabetes Technol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Endocrinology, Chinese PLA General Hospital , Beijing, China .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Needle with a novel attachment versus conventional screw-thread needles: a preference and usability ...
Next Document:  Novel Hormonal Delivery Method Using the Ink-Jet Technology: Application to Pulmonary Insulin Therap...